Molecule of the month: asoprisnil.
D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D004715:Endometriosis / Q000188:drug therapy*; D004963:Estrenes / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy*; D010091:Oximes / Q000627:therapeutic use*; D011980:Receptors, Progesterone / Q000819:agonists / Q000037:antagonists & inhibitors / Q000187:drug effects*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D004963:Estrenes; D010091:Oximes; D011980:Receptors, Progesterone; C488516:asoprisnil